Provided by Tiger Fintech (Singapore) Pte. Ltd.

Supernus Pharmaceuticals

33.15
+0.81002.50%
Post-market: 33.150.00000.00%16:35 EDT
Volume:354.75K
Turnover:11.65M
Market Cap:1.86B
PE:29.95
High:33.20
Open:32.72
Low:32.33
Close:32.34
Loading ...

Supernus announces Paragraph IV ANDA filings for Qelbree

TIPRANKS
·
29 May

Supernus Pharmaceuticals Inc - to Enforce Intellectual Property Rights for Qelbree - SEC Filing

THOMSON REUTERS
·
29 May

Supernus:Got Paragraph Iv Notice Letters Notifying Third Parties Submitted Andas for Viloxazine Extended-Release Capsules EQ 100, 150, 200 Mg Base

THOMSON REUTERS
·
29 May

Supernus Announces Paragraph Iv Anda Filings for Qelbree

THOMSON REUTERS
·
29 May

Supernus Pharmaceuticals Announces Receipt of Paragraph IV ANDA Filings for Qelbree, Plans to Defend Patents

Reuters
·
29 May

Supernus Pharmaceuticals Inc. to Participate in Jefferies Global Healthcare Conference

Reuters
·
29 May

Optimistic Growth Prospects for Supernus Pharmaceuticals Driven by Qelbree’s Market Potential

TIPRANKS
·
07 May

Earnings Flash (SUPN) Supernus Pharmaceuticals Q1 Loss Per Share $0.21 Vs. FactSet Est. Loss $0.01

MT Newswires Live
·
07 May

Supernus Pharmaceuticals Q1 2025 GAAP EPS $(0.21), Sales $149.824M Beat $146.936M Estimate

Benzinga
·
07 May

Earnings Flash (SUPN) Supernus Pharma Q1 Revenue $149.8 Million Vs. FactSet Est. $147.9 Million

MT Newswires Live
·
07 May

BRIEF-Supernus Pharmaceuticals Q1 Adjusted Operating Earnings USD 25.9 Million Vs. IBES Estimate USD 24.1 Million

Reuters
·
07 May

Supernus Announces First Quarter 2025 Financial Results

THOMSON REUTERS
·
07 May

Supernus Pharmaceuticals Outlook FY Revenue USD 600-630 Million

THOMSON REUTERS
·
07 May

Supernus Pharmaceuticals Earnings: What To Look For From SUPN

StockStory
·
05 May

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory
·
29 Apr

What Makes Supernus (SUPN) a New Buy Stock

Zacks
·
29 Apr

3 Healthcare Stocks with Mounting Challenges

StockStory
·
24 Apr

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory
·
10 Apr

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

StockStory
·
08 Apr

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory
·
02 Apr